EU commission gives the go-ahead for the approval of Moderna’s COVID-19 vaccine
mRNA-1273 was authorized for immediate distribution and use by the EU.
Many people believe they are well informed on the COVID-19 pandemic
The study was funded by the Nuffield Foundation and UK Research and…
Researchers explore the anxiolytic effects of cannabis for COVID-19-induced anxiety
The data of 2,306 participants were assessed to track their consumption of…
NVX-CoV2373 enters Phase 3 trial for combatting SARS-CoV-2
Novavax is now enrolling adult volunteers in the United States and in…
Infants do not seem to be much affected by SARS-CoV-2
The research was released in JAMA Network Open.
Patients who are infected with COVID-19 are at a lower risk of reinfection
It is speculated that such antibodies could last for as much as…
Women experiencing more mental health problems as a result of COVID-19 isolation
Researchers unmasked a slew of mental health problems women, in particular, have…
Most Americans say they changed their holiday plans due to COVID-19 pandemic
The survey took place in mid-November 2020.
BioNTech-Pfizer COVID-19 vaccine labeled as safe for wide-scale distribution by the EU
The European Medicines Agency greenlighted its approval by reassuring the vaccine meets…
13 percent of US adults report severe mental distress during COVID-19 pandemic
The survey touched on numerous factors including employment, finances, education, and health…
Moderna’s COVID-19 vaccine touted as strongly effective by FDA advisers
FDA advisers recommend Moderna's mRNA-1273 for immediate use to combat COVID-19.
Study shows shrugging CDC guidelines results in anxiety and anger in the workplace
The study was authored by Renata Guzzo, Xingyu Wang, Juan Madera, and…